Nitric Oxide Production in Relation to Spontaneous B-Cell Lymphoma and Myositis in SJL Mice

Cancer Research

Volumn 55, Issue 19, 1995, Pages 4391-4397

  Tamir, Snait ^a   de Rojas Walker, Teresa ^a   Gal, Aharon ^a   Fox, James G ^a   Wogan, Gerald N ^a   Tannenbaum, Steven R ^a,a   Li, Xiantang ^a   Weller, Ann H ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Colorado Neurological Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID OXIDOREDUCTASES; ANIMAL; DNA DAMAGE; FEMALE; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MYOSITIS; NITRIC OXIDE; NITRIC-OXIDE SYNTHASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029047569     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Murphy, E. D. SJL/J, a new inbred strain of mouse with a high, early incidence of reticulum cell neoplasm. Proc. Am. Assoc. Cancer Res., 4: 46, 1963.
2. Pattengale, P. K., and Taylor, C. R. Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias. Am. J. Pathol., 113: 237–265, 1983.
3. Lerman, S. P., Carswell, E. A., Chapman, J., and Thorbecke, G. J. Properties of reticulum cell sarcomas in SJL/J mice. HI. Promotion of tumor growth in irradiated mice by normal lymphoid cells. Cell. Immunol., 23: 53–67, 1976.
4. Katz, I. R., Chapman-Alexander, J., Jacobson, E. B., Lerman, S. P., and Thorbeck, G. J. Growth of SJL/J derived transplantable reticulum cell sarcomas as related to its ability to induce T-cell proliferation in the host. Cell. Immunol., 65: 84–92, 1981.
5. Tsiagbe, V. K., Yoshimoto, T., Asakawa, J., Cho, S. Y., Meruelo, D., and Thorbecke, G. J. Linkage of superantigen-like stimulation of syngenic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J., 12: 2313–2320, 1993.
6. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 6: 3051–3064, 1992.
7. Lancaster, J. R., Jr. Nitric oxide in cells. Am. Sci., 80: 248–259, 1992.
8. Marietta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D., and Wishnok, J. S. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry, 27: 8706–8711, 1988.
9. Leaf, C. D., Wishnok, J. S., and Tannenbaum, S. R. L-arginine is a precursor for nitrate biosynthesis in humans. Biochem. Biophys. Res. Commun. 163: 1032–1037, 1989.
10. Marietta, M. A. Nitric oxide synthase structure and mechanism. J. Biol. Chem., 268: 12231–12234, 1993.
11. Karupiah, G., Xie, Q. W., Buller, R. M., Nathan, C., Durate, C., and MacMicking, J. D. Inhibition of viral replication by interferon. Science (Washington DC), 261: 1445–1448, 1993.
12. Radomski, M. W., Palmer, R. M. J., and Moncada, S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA, 87: 5193–5197, 1990.
13. Moncada, S., Palmer, R. M. J., and Higgs, E. A. Nitric oxide: physiology, pathology and pharmacology. Pharmacol. Rev., 43: 109–142, 1991.
14. Nathan, C. F., and J. B. Hibbs, Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol., 3: 65–70, 1991.
15. Bredt, D. S., and Snyder, S. H. Nitric oxide: a physiologic messenger molecule. Ann. Rev. Biochem., 63: 175–195, 1994.
16. Tannenbaum, S. R., Tamir, S., deRojas-Walker, T., and Wishnok, J. S. DNA damage and cytotoxicity by nitric oxide. In: R. A. Loeppky and C. J. Michejda (eds.), ACS Symposium Series 553: Nitrosamines and Related W-Nitroso Compounds, pp. 120–135. Washington, DC: American Chemical Society, 1994.
17. Nguyen, T., Branson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., and Tannenbaum, S. R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA, 89: 3030–3034, 1992.
18. Wink, D. A., Kasprzak, K. S., Maragos, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., and Keefer, L. K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Washington DC), 254: 1001–1003, 1991.
19. Pick, E., and Keisari, Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J. Immunol. Methods, 38: 161–170, 1980.
20. Ponzio, N. M., Hayama, T., Nagler, C., Katz, I. R., Hoffmann, M. K., Gilbert, K., Vilcek, J., and Thorbecke, G. J. Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production of antibody-enhancing factor, interleukin 2, and immune interferon. J. Natl. Cancer Inst., 72: 311–320, 1984.
21. Lasky, J. L., and Thorbecke, G. J. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Eur. J. Immunol., 19: 365–371, 1989.
22. Balligand, J.-L., Ungurreanu-Longrois, D., Simmons, W. W., Kobzik, L., Lowenstein, C. J., Lamas, S., Kelly, R. A., Smith, T. W., and Michel, T. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-10 and IFN-7. Am. J. Physiol. 268: H1293–H1303, 1995.
23. Alleva, D. G., Burger, C. J., and Elgert, K. D. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-a production: role of tumor-derived IL-10, TGF-0 and prostaglandin Ej. J. Immunol., 153: 1674–1686, 1994.
24. Sicher, S. C., Vazquez, M. A., and Christopher, Y. L. Inhibition of macrophage la expression by nitric oxide. J. Immunol., 153: 1293–1300, 1994.
25. Granger, D. L., Hibbs, J. B. Jr., Perfect, J. R., and Durack, D. T. Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest., 85: 264–273, 1990.
26. Vodovotz, Y., Kwon, N. Y., Pospischil, M., Manning, J., Paik, J., and Nathan, C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-7 and bacterial lipopolysaccharide. J. Immunol., 152: 4110–4118, 1994.
27. Farias-Eisner, R., Sherman, M. P., Aeberhard, E., and Chaudhuri, G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. USA, 91: 9407–9411, 1994.
28. Dong, Z., Staroselsky, A. H., Qi, X., Xie, K., and Fidler, J. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res., 54: 789–793, 1994.
29. Duffie, G. P., and Young, M. R. Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma. J. Leukocyte Biol., 49: 8–14, 1991.
30. Upton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., and Stamler, J. S. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds. Nature (Lond.), 364: 626–632, 1993.
31. Fu, Y., and Blankenhorn, E. P. Nitric oxide-induced antimitogenic effects in high and low responder rat strains. J. Immunol., 148: 2217–2222, 1992.
32. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265–270, 1992.
33. Mills, C. D., Shearer, J., Evans, R., and Caldwell, M. D. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J. Immunol., 149:2709–2714, 1992.
34. Mulligan, M. S., Hevel, J. M., Marietta, M. A., and Ward, P. A. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. USA, 88: 6338–6342, 1991.
35. Farrell, A. J., Blake, D. R., Palmer, R. M. J., and Moncada, S. Increased concentrations of nitrite in synovial fluid and serum samples suggests increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis., 51: 1219–1222, 1992.
36. Stcfanovic-Pacic, M., Meyers, K., Meschter, C., Coffy, J. W., Hoffman, R. A., and Evans, C. H. W-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum., 37:1062–1069,1994.
37. Rosenberg, N. L., Ringel, S. P., and Kotzin, B. L. Experimental autoimmune myositis in SJL/J mice. Clin. Exp. Immunol., 68: 117–129, 1987.
38. Beckman, J., and Crow, J. P. Pathological implications of nitric oxide, superoxide, and peroxynitrite formation. Biochem. Soc. Trans., 21: 330–334, 1993.
39. Noronha-Dutra, A. A., Epperlein, M. M., and Woolf, N. Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as model for nitric oxide-mediated killing. FEBS Lett., 321: 59–62, 1993.
40. Mayhan, W. G. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5’-diphosphate and bradykinin. Inflammation, 16: 295–305, 1992.
41. Lander, H. M., Sehajpal, P., Levin, D. M., and Novogrodsky, A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol., 150: 1509–1516, 1993.
42. Weinberg, J. B., Granger, D. L., Pisetsky, S. D., Seldin, M. R., Misukonis, M. A., Mason, S. N., Pippen, M. A., Ruiz, P., Wood, E. R., and Gilkeson, G. S. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered W-monomethyl-L-arginine. J. Exp. Med., 179: 651–660, 1994.
43. Ohshima, H., and Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res., 305: 253–264, 1994.
44. Kehrer, J. P. Free radicals as mediators of tissue injury and disease. Crit. Rev. Toxicol., 23: 21–48, 1993.